NL8101349A - Nieuwe bacteriemutanten, werkwijze voor het maken daarvan en levende vaccins met deze mutanten daarin. - Google Patents

Nieuwe bacteriemutanten, werkwijze voor het maken daarvan en levende vaccins met deze mutanten daarin. Download PDF

Info

Publication number
NL8101349A
NL8101349A NL8101349A NL8101349A NL8101349A NL 8101349 A NL8101349 A NL 8101349A NL 8101349 A NL8101349 A NL 8101349A NL 8101349 A NL8101349 A NL 8101349A NL 8101349 A NL8101349 A NL 8101349A
Authority
NL
Netherlands
Prior art keywords
coli
mutant
mutants
bacteria
immunization
Prior art date
Application number
NL8101349A
Other languages
English (en)
Dutch (nl)
Original Assignee
Univ Ramot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ramot filed Critical Univ Ramot
Publication of NL8101349A publication Critical patent/NL8101349A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NL8101349A 1980-03-19 1981-03-19 Nieuwe bacteriemutanten, werkwijze voor het maken daarvan en levende vaccins met deze mutanten daarin. NL8101349A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL59663A IL59663A (en) 1980-03-19 1980-03-19 Vaccines obtained from bacterial mutant strains of enterobacteriaceae and pseudomonaceae
IL5966380 1980-03-19

Publications (1)

Publication Number Publication Date
NL8101349A true NL8101349A (nl) 1981-10-16

Family

ID=11051694

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8101349A NL8101349A (nl) 1980-03-19 1981-03-19 Nieuwe bacteriemutanten, werkwijze voor het maken daarvan en levende vaccins met deze mutanten daarin.

Country Status (8)

Country Link
US (1) US4404186A (fr)
DE (1) DE3110801A1 (fr)
FR (1) FR2481928A1 (fr)
GB (1) GB2076287B (fr)
IL (1) IL59663A (fr)
IT (1) IT1136944B (fr)
NL (1) NL8101349A (fr)
ZA (1) ZA811662B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1217303B (it) * 1984-02-01 1990-03-22 Enterovax Res Pty Ltd Ceppi batterici particolarmente utili per la produzione di vaccini per il trattamenmto di malattie intestinali e simili e metodo di ingegneria gentica per la produzione dei detti vaccini
IE940698L (en) * 1984-04-05 1985-10-05 Univ Missouri Vaccine and serum for endotoxin associated disease and method of preparing same as well as to methods of immunization and treatment of such disease and to a detoxified endotoxin and bacterial mutant
US4764370A (en) * 1984-09-12 1988-08-16 Scripps Clinic And Research Foundation Vaccine utilizing an avirulent strain of Salmonella typhimurium
US4789544A (en) * 1986-05-23 1988-12-06 Midcon Labs. Inc. Co-vaccination using non-O-carbohydrate side-chain gram-negative bacteria preparation
DE3750725T2 (de) * 1986-05-23 1995-06-08 Sanofi Animal Health Inc GEMEINSAME IMPFUNG UNTER VERWENDUNG EINER PRAPARATION GRAM-NEGATIVER BAKTERIEN OHNE O-SPEZIFISCHEN KOHlEHYDRATSEITENKETTEN.
US5124153A (en) * 1987-08-24 1992-06-23 University Of Tennessee Research Corp. Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products
GB8912330D0 (en) * 1989-05-30 1989-07-12 Wellcome Found Live vaccines
US5302388A (en) * 1991-11-13 1994-04-12 Wisconsin Alumni Research Foundation Control of campylobacter jejuni colonization
ATE173166T1 (de) * 1992-09-04 1998-11-15 Univ Saskatchewan Neue bakterielle impfstoffe unter verwendung von impfstämmen von pathogenen bakterien
US5549899A (en) * 1992-12-04 1996-08-27 University Technologies International, Inc. Giardia vaccine
US5512288A (en) * 1992-12-04 1996-04-30 University Technologies International, Inc. Giardia vaccine
US5641491A (en) * 1993-06-15 1997-06-24 The Penn State Research Foundation Escherichia coli strain 364 and use of said strain as a vaccine
US6096322A (en) * 1993-06-15 2000-08-01 The Penn State Research Foundation Pathogenicity and protective attributes of major clones of Escherichia coli recovered from chickens during processing
US6117453A (en) * 1995-04-14 2000-09-12 Pharma Pass Solid compositions containing polyethylene oxide and an active ingredient
US5891692A (en) * 1996-03-29 1999-04-06 Life Technologies, Inc. Method for increasing the viability and transformation ability of bacteria during or after storage at low temperatures
US6713073B1 (en) * 1998-07-24 2004-03-30 Megan Health, Inc. Method of vaccination of newly hatched poultry

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE651300A (fr) * 1963-08-01 1900-01-01
US3907987A (en) * 1972-05-25 1975-09-23 Canadian Patents Dev Enteric disease vaccine
US3975517A (en) * 1972-05-25 1976-08-17 Canadian Patents And Development Limited Enteric disease vaccine
GB1472624A (en) * 1974-09-02 1977-05-04 Canadian Patents Dev Enteric disease vaccine
US4311797A (en) * 1979-09-18 1982-01-19 University Of Saskatchewan Anucleated live E. coli vaccine

Also Published As

Publication number Publication date
GB2076287B (en) 1984-02-22
IL59663A (en) 1983-02-23
FR2481928B1 (fr) 1984-07-13
ZA811662B (en) 1982-03-31
IT1136944B (it) 1986-09-03
FR2481928A1 (fr) 1981-11-13
GB2076287A (en) 1981-12-02
DE3110801A1 (de) 1982-01-07
IT8120393A0 (it) 1981-03-18
IL59663A0 (en) 1980-06-30
US4404186A (en) 1983-09-13

Similar Documents

Publication Publication Date Title
NL8101349A (nl) Nieuwe bacteriemutanten, werkwijze voor het maken daarvan en levende vaccins met deze mutanten daarin.
Curtiss III et al. Live oral avirulent Salmonella vaccines
Heddleston et al. Fowl cholera: cross-immunity induced in turkeys with formalin-killed in-vivo-propagated Pasteurella multocida
Deb et al. Laboratory trials with inactivated vaccines against Escherichia coli (O78 K80) infection in fowls
DE2836507C2 (fr)
DE69925371T2 (de) Impfstoff für geflügel
CA2134835C (fr) Vaccins de virulence attenuee administres in ovo
Sandhu Immunogenicity and safety of a live Pasteurella anatipestifer vaccine in White Pekin ducklings: laboratory and field trials
DE69925585T2 (de) Bakterien abgeschwächt durch eine nicht revertierende mutation in jeden der aroc, ompf und ompc gene, verwendbar als impfstoff
DE60011560T2 (de) Salmonella Impfstoff, der keinen Antikörper gegen Flagellin oder gegen Flagella induziert
Barrow Immunity to experimental fowl typhoid in chickens induced by a virulence plasmid-cured derivative of Salmonella gallinarum
DE602004010643T2 (de) E. coli vakzin zur protektion von geflügel gegen colibazillose
AU2004240585B2 (en) Avian combination-vaccine against E.coli and Salmonella
Chima et al. Immunoprophylaxis of experimental Mycoplasma bovis arthritis in calves. Protective efficacy of live organisms and formalinized vaccines
Rimler et al. A growth medium for the production of a bacterin for immunization against infectious coryza
DE2843295A1 (de) Verfahren zur herstellung stabiler avirulenter und hochimmunogener bakterienmutanten fuer lebendimpfstoffe
Diena et al. Assay of typhoid vaccines with Salmonella typhosa-Salmonella typhimurium hybrids
Kagaya et al. Antigenic role of stress-induced catalase of Salmonella typhimurium in cell-mediated immunity
Chadwick Effects of immunization on the LD50 of two pathogens of Galleria mellonella
Bedrnik et al. Field vaccination of broilers against coccidiosis
Nathanson et al. Cyclophosphamide-induced immunosuppression demonstrated in Pasteurella multocida-vaccinated chickens
RU2761379C1 (ru) Поливалентная инактивированная вакцина против стрептококкозов свиней, способ ее получения и применения
Loan et al. A tissue culture-derived Pasteurella haemolytica vaccine
JPH085802B2 (ja) 家禽大腸菌症ワクチン
RU2030916C1 (ru) Вакцина против сальмонеллеза кур и способ профилактики сальмонеллеза кур

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BN A decision not to publish the application has become irrevocable